What are the guidelines for the management of alpha1-antitrypsin deficiency (AATD)?

Updated: Sep 11, 2020
  • Author: Dora E Izaguirre Anariba, MD, MPH; Chief Editor: John J Oppenheimer, MD  more...
  • Print

Management recommendations are as follows:

  • The use of intravenous augmentation therapy for individuals with established airflow obstruction from AATD

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!